Works matching IS 00207136 AND DT 2019 AND VI 144 AND IP 11


Results: 29
    2
    3
    4

    Reply to letter: Thyroid neoplasia after Chernobyl: A comment.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2898, doi. 10.1002/ijc.32213
    By:
    • Tronko, Mykola;
    • Brenner, Alina V.;
    • Bogdanova, Tetiana;
    • Shpak, Victor;
    • Cahoon, Elizabeth K.;
    • Drozdovitch, Vladimir;
    • Little, Mark P.;
    • Tereshchenko, Valeriy;
    • Zamotayeva, Galyna;
    • Terekhova, Galyna;
    • Zurnadzhi, Lyudmila;
    • Hatch, Maureen;
    • Mabuchi, Kiyohiko
    Publication type:
    Article
    5

    Erratum.

    Published in:
    2019
    Publication type:
    Correction Notice
    6
    7

    Application of patient‐derived liver cancer cells for phenotypic characterization and therapeutic target identification.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2782, doi. 10.1002/ijc.32026
    By:
    • Castven, Darko;
    • Becker, Diana;
    • Czauderna, Carolin;
    • Wilhelm, Diana;
    • Andersen, Jesper B.;
    • Strand, Susanne;
    • Hartmann, Monika;
    • Heilmann‐Heimbach, Stefanie;
    • Roth, Wilfried;
    • Hartmann, Nils;
    • Straub, Beate K.;
    • Mahn, Friederike L.;
    • Franck, Sophia;
    • Pereira, Sharon;
    • Haupts, Anna;
    • Vogel, Arndt;
    • Wörns, Marcus A.;
    • Weinmann, Arndt;
    • Heinrich, Stefan;
    • Lang, Hauke
    Publication type:
    Article
    8

    Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2887, doi. 10.1002/ijc.32025
    By:
    • Lin, Yen‐Ting;
    • Chen, Jin‐Shing;
    • Liao, Wei‐Yu;
    • Ho, Chao‐Chi;
    • Hsu, Chia‐Lin;
    • Yang, Ching‐Yao;
    • Chen, Kuan‐Yu;
    • Lee, Jih‐Hsiang;
    • Lin, Zhong‐Zhe;
    • Shih, Jin‐Yuan;
    • Yang, James Chih‐Hsin;
    • Yu, Chong‐Jen
    Publication type:
    Article
    9
    10
    11

    Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2762, doi. 10.1002/ijc.32010
    By:
    • Lee‐Vergés, Eriong;
    • Hanna, Bola S.;
    • Yazdanparast, Haniyeh;
    • Rodríguez, Vanina;
    • Rodríguez, Marta Leonor;
    • Giró, Ariadna;
    • Vidal‐Crespo, Anna;
    • Rosich, Laia;
    • Amador, Virginia;
    • Aymerich, Marta;
    • Villamor, Neus;
    • Delgado, Julio;
    • Lichter, Peter;
    • Pérez‐Galán, Patricia;
    • López‐Guerra, Mònica;
    • Campo, Elías;
    • Seiffert, Martina;
    • Colomer, Dolors
    Publication type:
    Article
    12
    13
    14
    15

    Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2695, doi. 10.1002/ijc.31999
    By:
    • Papakonstantinou, Nikos;
    • Ntoufa, Stavroula;
    • Tsagiopoulou, Maria;
    • Moysiadis, Theodoros;
    • Bhoi, Sujata;
    • Malousi, Andigoni;
    • Psomopoulos, Fotis;
    • Mansouri, Larry;
    • Laidou, Stamatia;
    • Papazoglou, Despoina;
    • Gounari, Maria;
    • Pasentsis, Konstantinos;
    • Plevova, Karla;
    • Kuci‐Emruli, Venera;
    • Duran‐Ferrer, Marti;
    • Davis, Zadie;
    • Ek, Sara;
    • Rossi, Davide;
    • Gaidano, Gianluca;
    • Ritgen, Matthias
    Publication type:
    Article
    16

    Relationship of DNA methylation to mutational changes and transcriptional organization in fusion‐positive and fusion‐negative rhabdomyosarcoma.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2707, doi. 10.1002/ijc.32006
    By:
    • Sun, Wenyue;
    • Chatterjee, Bishwanath;
    • Shern, Jack F.;
    • Patidar, Rajesh;
    • Song, Young;
    • Wang, Yonghong;
    • Walker, Robert L.;
    • Pawel, Bruce R.;
    • Linardic, Corinne M.;
    • Houghton, Peter;
    • Hewitt, Stephen M.;
    • Edelman, Daniel C.;
    • Khan, Javed;
    • Meltzer, Paul S.;
    • Barr, Frederic G.
    Publication type:
    Article
    17

    Challenges in assessing the sunscreen‐melanoma association.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2651, doi. 10.1002/ijc.31997
    By:
    • Rueegg, Corina S.;
    • Stenehjem, Jo S.;
    • Egger, Matthias;
    • Ghiasvand, Reza;
    • Cho, Eunyoung;
    • Lund, Eiliv;
    • Weiderpass, Elisabete;
    • Green, Adele C.;
    • Veierød, Marit B.
    Publication type:
    Article
    18
    19
    20

    A plasma metabolite panel as biomarkers for early primary breast cancer detection.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2833, doi. 10.1002/ijc.31996
    By:
    • Yuan, Baowen;
    • Schafferer, Simon;
    • Tang, Qiuqiong;
    • Scheffler, Matthias;
    • Nees, Juliane;
    • Heil, Jörg;
    • Schott, Sarah;
    • Golatta, Michael;
    • Wallwiener, Markus;
    • Sohn, Christof;
    • Koal, Therese;
    • Wolf, Barbara;
    • Schneeweiß, Andreas;
    • Burwinkel, Barbara
    Publication type:
    Article
    21

    The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2683, doi. 10.1002/ijc.31992
    By:
    • Schubert, Stephanie;
    • Luttikhuizen, Jana L.;
    • Auber, Bernd;
    • Schmidt, Gunnar;
    • Hofmann, Winfried;
    • Penkert, Judith;
    • Davenport, Colin F.;
    • Hille‐Betz, Ursula;
    • Wendeburg, Lena;
    • Bublitz, Janin;
    • Tauscher, Marcel;
    • Hackmann, Karl;
    • Schröck, Evelin;
    • Scholz, Caroline;
    • Wallaschek, Hannah;
    • Schlegelberger, Brigitte;
    • Illig, Thomas;
    • Steinemann, Doris
    Publication type:
    Article
    22
    23
    24
    25

    Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2746, doi. 10.1002/ijc.31988
    By:
    • Fortunato, Orazio;
    • Borzi, Cristina;
    • Milione, Massimo;
    • Centonze, Giovanni;
    • Conte, Davide;
    • Boeri, Mattia;
    • Verri, Carla;
    • Moro, Massimo;
    • Facchinetti, Federica;
    • Andriani, Francesca;
    • Roz, Luca;
    • Caleca, Laura;
    • Huber, Veronica;
    • Cova, Agata;
    • Camisaschi, Chiara;
    • Castelli, Chiara;
    • Cancila, Valeria;
    • Tripodo, Claudio;
    • Pastorino, Ugo;
    • Sozzi, Gabriella
    Publication type:
    Article
    26
    27
    28

    Issue Information.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2627, doi. 10.1002/ijc.31681
    Publication type:
    Article
    29

    Issue Information.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 11, p. 2899, doi. 10.1002/ijc.31688
    Publication type:
    Article